Profund Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Profund Advisors's KRYS Position: Q3 2026 in Review
Profund Advisors increased its Krystal Biotech (KRYS) stake by 27% in Q3 2026, buying an estimated $534K and bringing the position to 7,313 shares worth $2.43M. The position accounts for 0.07% of the portfolio, ranked #164.
Profund Advisors first reported a position in KRYS in Q1 2023 and has held it in 15 quarters since. The position peaked at $2.44M in Q4 2025. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Profund Advisors held 7,313 shares of Krystal Biotech worth $2.43M as of Q3 2026.
- Profund Advisors bought 1,543 Krystal Biotech shares in Q3 2026, an estimated $534K.
- Krystal Biotech made up 0.07% of Profund Advisors's portfolio in Q3 2026, its #164 holding.
- Profund Advisors first reported a position in Krystal Biotech in Q1 2023 and has held it in 15 quarters since.
- Profund Advisors's Krystal Biotech position peaked at $2.44M in Q4 2025.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.